C4 Therapeutics, Inc. (CCCC) Revenue History
C4 Therapeutics, Inc. (CCCC) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2020-12-31 | N/A |
| 2021-12-31 | $45.78M |
| 2022-12-31 | $31.10M |
| 2023-12-31 | $20.76M |
| 2024-12-31 | $35.58M |
| 2025-12-31 | $35.95M |
How CCCC compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc. | $49.80M |
| GOSS | Gossamer Bio Inc. | $48.47M |
| VYGR | Voyager Therapeutics Inc. | $40.37M |
| VRCA | Verrica Pharmaceuticals Inc. | $35.58M |
| EYPT | EyePoint Pharmaceuticals Inc. | $31.37M |
These are five companies in the same sector as CCCC with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get C4 Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("CCCC", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CCCC | $3.39 | -0.73% | 1.63M |
| 3 | ||||
| 4 | ||||
| 5 |